首页> 外文期刊>Scientific reports. >Elevated red cell distribution width to platelet count ratio predicts poor prognosis in patients with breast cancer
【24h】

Elevated red cell distribution width to platelet count ratio predicts poor prognosis in patients with breast cancer

机译:红细胞分布宽度与血小板计数比升高预示乳腺癌患者的预后不良

获取原文
获取外文期刊封面目录资料

摘要

Red cell distribution width (RDW) to platelet ratio (RPR) is a prognosticator in acute pancreatitis and myocardial infarction; however, the prognostic values of RDW and RPR in breast cancer have not been studied. This retrospective analysis of 299 breast cancer patients investigated the association between RDW and RPR and clinicopathological characteristics and prognosis, compared to platelet distribution width to platelet count ratio (PDW/P) which is a known independent prognostic factor in patients with breast cancer. We found a significant correlation between RPR, and age and HER2 status. An elevated RPR significantly correlated with age and HER2 status. After a median follow-up duration of 48 months, tumour size, nuclear grade, PDW/P, and RPR were recgnized to be significantly associated with lower disease-free survival rates (tumour size: p??0.01; nuclear grade, PDW/P, and RPR: p??0.05) in univariate analysis. Tumour size and RPR were significant prognostic factors for lower disease-free survival rates, with hazard ratios of 4.31 (95% confidence interval: 1.76-10.53) (p??0.01)] and 2.79 [95% confidence interval: 1.01-87.69) (p??0.05)], respectively, in a multivariate analysis using the Cox proportional hazards model. This is the first study showing that an elevated RPR could independently predict poor prognosis in patients with breast carcinoma. Thus, RPR could be a novel biomarker for prognostic estimation.
机译:红细胞分布宽度(RDW)与血小板比率(RPR)是急性胰腺炎和心肌梗塞的预后指标。然而,尚未研究RDW和RPR在乳腺癌中的预后价值。这项对299名乳腺癌患者的回顾性研究调查了RDW和RPR与临床病理特征和预后之间的关系,并与血小板分布宽度与血小板计数比(PDW / P)进行了比较,后者是已知的乳腺癌患者独立预后因素。我们发现RPR与年龄和HER2状态之间存在显着相关性。 RPR升高与年龄和HER2状态显着相关。在中位随访48个月后,发现肿瘤大小,核级,PDW / P和RPR与较低的无病生存率显着相关(肿瘤大小:p≤0.01;核级,PDW /P,RPR:p<0.05)。肿瘤大小和RPR是降低无病生存率的重要预后因素,危险比分别为4.31(95%置信区间:1.76-10.53)(p?<?0.01)]和2.79 [95%置信区间:1.01-87.69] )(p?<?0.05)],分别使用Cox比例风险模型进行多变量分析。这是第一项研究表明,RPR升高可以独立预测乳腺癌患者的不良预后。因此,RPR可能是一种用于预后评估的新型生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号